علاج النوبات الحادة في اضطراب طيف التهاب النخاع والعصب البصري

References

• A repeated treatment course has also been shown to improve outcomes and lower the number of non-responders.
• Thus, patients may benefit from repeated therapy courses (apheresis and/or glucocorticoids) if they insufficiently responded or continued exhibiting functional deficits after the first or second treatment course for NMOSD attacks.
• Other experimental therapy approaches, such as intravenous immunoglobulins (IVIG), early anti-CD20 therapy, and early anti-complement therapy, have been reported in single case series to possibly lead to favorable outcomes in acute attacks.

DOI: 10.1007/s00415-024-12288-2